Control of multiple gene expression using synthetic promoters.

JP2024511591A5Pending Publication Date: 2025-03-18ASTRAZENECA AB
0 Cites 0 Cited by

Patent Information

Application Number
JP2023556871
Authority / Receiving Office
JP · JP
Patent Type
Applications
Current Assignee / Owner
Priority Date
2021-03-16
Filing Date
2022-03-15
Publication Date
2025-03-18

AI Technical Summary

Technical Problem

Current methods for controlling the stoichiometry and co-expression of multiple recombinant genes in mammalian cells are limited by the number of genes that can be regulated, require multiple plasmids, and often impose metabolic burdens or cellular stress, making them complex and imprecise.

Method used

The use of synthetic promoters with defined transcriptional activity, linked to transcription factor regulatory elements, allows for precise control of multiple gene expression in multigene expression vectors, enabling predictable stoichiometry and reduced cellular stress.

Benefits of technology

The solution provides precise control over the expression levels of multiple genes, reducing cellular stress and metabolic burden, while allowing for predictable and efficient expression of recombinant proteins.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The present invention relates to expression vectors containing synthetic mammalian promoters capable of mediating the expression of multiple genes with predictable relative stoichiometry.
Need to check novelty before this filing date? Find Prior Art